DAVID BATES to Hypoglycemic Agents
This is a "connection" page, showing publications DAVID BATES has written about Hypoglycemic Agents.
Connection Strength
0.440
-
Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies. Pharmacoepidemiol Drug Saf. 2018 07; 27(7):781-788.
Score: 0.116
-
Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events. J Clin Epidemiol. 2016 09; 77:101-111.
Score: 0.102
-
How many medication orders are entered through free-text in EHRs?--a study on hypoglycemic agents. AMIA Annu Symp Proc. 2012; 2012:1079-88.
Score: 0.079
-
Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis. Semin Arthritis Rheum. 2024 Jun; 66:152441.
Score: 0.044
-
Unexpected hypoglycemia in a critically ill patient. Ann Intern Med. 2002 Jul 16; 137(2):110-6.
Score: 0.039
-
Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes. Am J Respir Crit Care Med. 2021 04 01; 203(7):924-925.
Score: 0.036
-
Digital Health and Patient Safety. JAMA. 2016 Apr 26; 315(16):1697-8.
Score: 0.025